2018: NIH licenses on Anti-Mesothelin CAR to Atara Biotherapeutics

Attached are comments from 8 health and fair groups regarding a prospective grant of an exclusive license to NIH owned patent, for the development of an Anti-Mesothelin Chimeric Antigen Receptor (CAR) for the treatment of human Cancer, to Atara Biotherapeutics… Continue Reading

1996 Paper on Trade and Pharmaceutical Policies for HAI Seminar on WTO/GATT, Bielefeld Germany

Comments on Trade and Pharmaceutical Policies: A Perspective from the U.S. Consumer Movement HAI Seminar: World Trade Organization/GATT, Pharmaceutical Policies and Essential Drugs October 4, 1996 Bielefeld, Germany James Love Center for Study of Responsive Law (1) I would like… Continue Reading